Frédéric Boisserie

机构：Solid Power (United States)

发表论文 24 篇 · 总被引 2529 次 · h-index 10

代表论文

Celecoxib for the Prevention of Sporadic Colorectal Adenomas (2006 · New England Journal of Medicine · 被引 1045)
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study (2014 · The Lancet Oncology · 被引 697)
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma (2023 · JAMA Oncology · 被引 257)
RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma (2019 · Future Oncology · 被引 153)
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma (2016 · Journal of Hepatology · 被引 130)
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma (2020 · British Journal of Cancer · 被引 120)